Back to today’s briefing

Story perspectives

Trump's Tariffs Could Trigger U.S. Drug Shortages

4/1/2025

47 4

Summary

Story summary

President Trump's proposed tariffs on Canadian pharmaceuticals threaten to create critical drug shortages in the U.S., impacting essential medications like antidepressants and HIV treatments. A study reveals that a 25% tariff could inflate costs by $750 million each year, raising alarms about the potential disruption of supply chains for both American and Canadian markets.

1 of 1

Story summary

President Trump's proposed tariffs on Canadian pharmaceuticals threaten to create critical drug shortages in the U.S., impacting essential medications like antidepressants and HIV treatments. A study reveals that a 25% tariff could inflate costs by $750 million each year, raising alarms about the potential disruption of supply chains for both American and Canadian markets.